- Efficacy and Safety of Interleukin-6-Knockdown CD19-Targeted CAR T Cells(ssCART-19) for Relapsed/Refractory B-ALLKang, Liqing; Ma, Jinfeng; Lou, Xiaoyan; Tang, Xiaowen; Xue, Shengli; Chen, Suning; Qiu, Huiying; Miao, Miao; Han, Yue; Wang, Ying; Sun, Aining; Dai, Haiping; Xu, Yang; Li, Limin; Fan, Shengjin; Qian, Chongsheng; Gong, Wenjie; Xu, Mingzhu; Zhou, Haixia; Yao, Zhen65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in AdultsTu, Sanfang; Zhou, Lijuan; Huang, Rui; Zhou, Xuan; Yang, Jilong; Li, Meifang; Jin, Bo; Wang, Langqi; Zhuo, Yaqi; Chen, Huifang; Chang, Lung-Ji; Li, Yuhua65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System InvolvementHe, Bailin; Zhou, Hongsheng; Lin, Ren; Wang, Zhixiang; Xu, Na; Wang, Qiang; Sun, Jing; Liu, Xiaoli; Li, Peng; Liu, Qifa65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
会议论文
Dendritic Cell Vaccines Extend CD19 CAR-T Cell Persistence and Improve the Outcomes in Refractory/Relapsed Adult B-ALL
10阅读
